BioSpace News Archive

Biotech Bay

NVIGEN Unveils Groundbreaking Comprehensive Liquid Biopsy at San Antonio Breast Cancer Symposium: Advancing Clinical Utility with Multimodal Biomarker Detection Enabled by Highly Versatile Nanoparticle Capture

NVIGEN, a leader in providing modern nanoparticle health care solutions, is poised to unveil its groundbreaking technology, NVIGEN X®-Precision Medicine Biomarker Profiling, at the San Antonio Breast Cancer Symposium from December 5 to 9.

December 5, 2023
·
4 min read
Pharm Country

Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023

Applied DNA Sciences, Inc. today announced that it will release its fourth quarter and full year financial results 2023 ended September 30, 2023, on Thursday, December 7, 2023, after the market close.

December 5, 2023
·
2 min read
Drug Development

G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy

G1 Therapeutics, Inc. today announced the presentation of new data describing the long-term positive survival impact of previous treatment with trilaciclib and cytotoxic chemotherapy (gemcitabine/carboplatin; GCb) in patients with metastatic triple negative breast cancer (mTNBC) who participated in G1’s Phase 2 trial (NCT02978716).

December 5, 2023
·
9 min read
Drug Development

BioInvent Presents Positive First Clinical Data on Anti-FcyRIIB Antibody BI-1607

BioInvent International today presents the first clinical data from a Phase 1/2a trial of its second FcyRIIB-blocking antibody BI-1607.

December 5, 2023
·
4 min read
FDA

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

Exactech announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA).

December 5, 2023
·
3 min read
Biotech Bay

Ceremorphic Life Sciences CEO Delivers Keynote at AI Driven Drug Discovery Summit; Demonstrates New Bio-supercomputing Platform that Can Speed Every Phase of Drug Discovery and Development

Ceremorphic Life Sciences CEO Venkat Mattela delivered the keynote at today’s AI Driven Drug Discovery Summit in Boston MA, where he demonstrated the company’s new BioCompDiscoverX supercomputing platform.

December 5, 2023
·
4 min read
Genetown

First Light Diagnostics Receives FDA Clearance for its Rapid B. anthracis Toxin Test on the MultiPath Analyzer

First Light Diagnostics announced that the US Food and Drug Administration (FDA) has cleared its SensiTox® B. anthracis Toxin Test to be marketed in the U.S.

December 5, 2023
·
3 min read
A Leading Global CDMO Continues to Drive Its Sustainability Strategy Forward: Vetter Joins Science Based Targets Initiative (SBTi)

Vetter, a leading globally operating Contract Development and Manufacturing Organization (CDMO), has joined the Science Based Targets Initiative (SBTi) membership group as of November 2023.

December 5, 2023
·
6 min read
Precision Oncology Market Size is Valued to Soar USD 258.35 Billion by 2032

The global precision oncology market size was estimated to grow from USD 100.06 billion in 2022 and is valued to soar USD 258.35 billion by 2032, at an expanding CAGR of 9.9% between 2023 and 2032.

December 5, 2023
·
8 min read
TrialSpark Rebrands as Formation Bio, Continuing Its Commitment to Advancing Drug Development Innovation

TrialSpark, a tech-driven drug developer with its own portfolio of clinical stage drug assets, is rebranding to Formation Bio.

December 5, 2023
·
4 min read